Olanzapine Injection, Powder, For Solution
Product Images NDC 72603-181

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 72603-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olanzapinecartonlabel (Olanzapinecartonlabel)

Packaging label of Olanzapine Injection, 10 mg per vial, powder for solution for intramuscular use. The label shows the NDC 72603-181-01 and indicates single-dose sterile vials. Manufactured by Aspiro Pharma Limited and labeled by NorthStar Rx LLC, the label includes storage and preparation instructions, inactive ingredients, and a barcode.*

FDA Label Image

Olanzapinestructure.jpg (Olanzapinestructure)

Chemical structure of olanzapine, showing its molecular arrangement including aromatic rings and heteroatoms nitrogen and sulfur.*

FDA Label Image

Olanzapinestructure (Olanzapineviallabel)

Label for Olanzapine for Injection 10 mg per vial, sterile single dose for intramuscular use only. Manufactured for Northstar Rx LLC, Memphis, TN, and by Aspiro Pharma Limited, Telangana, India. The label includes an NDC number, barcode, lot and expiration placeholders, and advises to see accompanying literature for dosage and administration instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.